Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

November 01, 1989; Volume 251,Issue 2
  • You have access
    Agonist recognition site of the peripheral acetylcholine receptor ion channel complex differentiates the enantiomers of nicotine.
    R Rozental, Y Aracava, G T Scoble, K L Swanson, S Wonnacott and E X Albuquerque
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 395-404;
  • You have access
    Effects of chronic morphine administration on the mu and delta opioid responses in the CA1 region of the rat hippocampus.
    T L Wimpey, K E Opheim and C Chavkin
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 405-411;
  • You have access
    Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions.
    E T Iwamoto
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 412-421;
  • You have access
    D2/D1 ratio in the medial preoptic area affects copulation of male rats.
    E M Hull, R K Warner, T J Bazzett, R C Eaton, J T Thompson and L L Scaletta
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 422-427;
  • You have access
    Neuroendocrine evidence for denervation supersensitivity of serotonin receptors: effects of the 5-HT agonist RU 24969 on corticotropin, corticosterone, prolactin and renin secretion.
    L D Van de Kar, M Carnes, R J Maslowski, A M Bonadonna, P A Rittenhouse, K Kunimoto, R A Piechowski and C L Bethea
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 428-434;
  • You have access
    Pharmacokinetics of naloxone: an insight into the locus of effect on stress-ulceration.
    R L Kleiman-Wexler, C G Adair and K S Ephgrave
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 435-438;
  • You have access
    Inhibition of endopeptidase 24.15 slows the in vivo degradation of luteinizing hormone-releasing hormone.
    A Lasdun, S Reznik, C J Molineaux and M Orlowski
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 439-447;
  • You have access
    Cysteine S-conjugates may act as kidney-selective prodrugs: formation of 6-mercaptopurine by the renal metabolism of S-(6-purinyl)-L-cysteine.
    I Y Hwang and A A Elfarra
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 448-454;
  • You have access
    Reinforcing effect of alfentanil is mediated by mu opioid receptors: apparent pA2 analysis.
    A J Bertalmio and J H Woods
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 455-460;
  • You have access
    Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.
    J A Clark, L Liu, M Price, B Hersh, M Edelson and G W Pasternak
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 461-468;
  • You have access
    Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
    M A Gistrak, D Paul, E F Hahn and G W Pasternak
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 469-476;
  • You have access
    Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite.
    D Paul, K M Standifer, C E Inturrisi and G W Pasternak
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 477-483;
  • You have access
    SK&F 104353: selective antagonism of peptidoleukotrine-induced changes in electrolyte transport by rat ileal mucosa in vitro.
    E Elton, D C Chiossone, G P McCafferty, F M Ryan and P L Smith
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 484-489;
  • You have access
    Pharmacologic experiments on the interaction between crotoxin and the mammalian neuromuscular junction.
    S Trivedi, I I Kaiser, M Tanaka and L L Simpson
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 490-496;
  • You have access
    Opioid-induced prejunctional inhibition of vasoconstriction in the rabbit ear artery: alpha-2 adrenoceptor activation and external calcium.
    D Budai and S P Duckles
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 497-501;
  • You have access
    Effects of Bay o 2752, a hypocholesterolemic agent, on intestinal taurocholate absorption and cholesterol esterification.
    K M Harnett, C T Walsh and L H Zhang
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 502-509;
  • You have access
    Analogs of somatostatin selectively label distinct subtypes of somatostatin receptors in rat brain.
    K Raynor and T Reisine
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 510-517;
  • You have access
    Glutamate receptors of the N-methyl-D-aspartate subtype in the myenteric plexus of the guinea pig ileum.
    H E Shannon and B D Sawyer
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 518-523;
  • You have access
    Serotonin depletion potentiates gastric secretory and motor responses to vagal but not peripheral gastric stimulants.
    R L Stephens, T Garrick, H Weiner and Y Taché
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 524-530;
  • You have access
    Antagonism to the actions of platelet activating factor by a nonpsychoactive cannabinoid.
    S H Burstein, C A Audette, S A Doyle, K Hull, S A Hunter and V Latham
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 531-535;
  • You have access
    A mu-specific opioid peptide agonist increases excitability of pyramidal neurons in untreated and receptor up-regulated hippocampus.
    A M Moudy, C J Coscia and M B Laskowski
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 536-542;
  • You have access
    Aging does not alter brain muscarinic receptor-mediated phosphoinositide hydrolysis and its inhibition by phorbol esters, tetrodotoxin and receptor desensitization.
    W Surichamorn, E A Abdallah and E E el-Fakahany
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 543-549;
  • You have access
    Role of adenosine in the gastric blood flow response to pentagastrin in the rat.
    J G Gerber and P H Guth
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 550-556;
  • You have access
    Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
    T A Morinelli, J E Oatis, A K Okwu, D E Mais, P R Mayeux, A Masuda, D R Knapp and P V Halushka
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 557-562;
  • You have access
    Importance of central nervous system serotonin-1A receptors for mediating the hypotensive effect of urapidil.
    A K Mandal, K J Kellar, E Friedman, S V Pineo, P Hamosh and R A Gillis
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 563-570;
  • You have access
    Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.
    A C Uprichard, L G Chi, J M Kitzen, J J Lynch, J W Frye and B R Lucchesi
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 571-577;
  • You have access
    Angiotensin II receptor-mediated stimulation of cytosolic-free calcium and inositol phosphates in chick myocytes.
    K M Baker, H A Singer and J F Aceto
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 578-585;
  • You have access
    The anticholinergic activity of agents indicated for urinary incontinence is an important property for effective control of bladder dysfunction.
    L Noronha-Blob, V C Lowe, J S Peterson and R C Hanson
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 586-593;
  • You have access
    Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice.
    E K Hong and A E Takemori
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 594-598;
  • You have access
    Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
    C R Bowden and C S Marchione
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 599-605;
  • You have access
    Development and application of a radioimmunoassay for physostigmine.
    H G Meyer, B J Lukey, R T Gepp, M P McCluskey and C N Lieske
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 606-611;
  • You have access
    Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers.
    R J Mandel, A D Chen, D J Connor and L J Thal
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 612-619;
  • You have access
    Neutrophils delay functional recovery of the post-hypoxic heart of the rabbit.
    R Kraemer and K M Mullane
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 620-626;
  • You have access
    Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
    J Willetts and R L Balster
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 627-633;
  • You have access
    Influence of protein kinase C activators on vascular tone and adrenergic neuroeffector events in the isolated rat kidney.
    E Sehic and K U Malik
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 634-639;
  • You have access
    Alpha-2A and alpha-2B adrenergic receptor subtypes: attenuation of cyclic AMP production in cell lines containing only one receptor subtype.
    D B Bylund and C Ray-Prenger
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 640-644;
  • You have access
    Selective pressor enhancement by monoamine oxidase inhibitors in conscious rats.
    L Kerecsen and R D Bunag
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 645-649;
  • You have access
    Amiodarone blocks calcium current in single guinea pig ventricular myocytes.
    M Nishimura, C H Follmer and D H Singer
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 650-659;
  • You have access
    Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart.
    F J Ehlert, F M Delen, S H Yun, D J Friedman and D W Self
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 660-671;
  • You have access
    Dihydropyridine-sensitive and -insensitive components of acetylcholine release from rat motor nerve terminals.
    W D Atchison
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 672-678;
  • You have access
    Antiangiogenic action of heparin plus cortisone is associated with decreased collagenous protein synthesis in the chick chorioallantoic membrane system.
    M E Maragoudakis, M Sarmonika and M Panoutsacopoulou
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 679-682;
  • You have access
    The effect of age on antipyrine pharmacokinetics and metabolite formation in rats.
    C F van Bezooijen and R M van Oorschot
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 683-686;
  • You have access
    Phorbol esters and D2-dopamine receptors.
    L X Cubeddu, T W Lovenberg, I S Hoffman and R K Talmaciu
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 687-693;
  • You have access
    Effect of synthesis inhibitors of thromboxane A2 and prostaglandin E2 on the regulation of sodium and water.
    J L Reyes, E Meléndez, B A Escalante and M C Namorado
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 694-699;
  • You have access
    Dihydropyridine calcium antagonists reduce the consumption of high-energy phosphates in the rat brain. A study using combined 31P/1H magnetic resonance spectroscopy and 31P saturation transfer.
    M Rudin and A Sauter
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 700-706;
  • You have access
    An erythromycin derivative, EM-523, induces motilin-like gastrointestinal motility in dogs.
    N Inatomi, H Satoh, Y Maki, N Hashimoto, Z Itoh and S Omura
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 707-712;
  • You have access
    Pharmacological characterization of [Leu-13-psi-CH2NH-Leu14]-bombesin as a specific bombesin receptor antagonist on isolated smooth muscle cells.
    C Severi, D H Coy, R T Jensen, L Boschero, M C Anania and G Delle Fave
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 713-717;
  • You have access
    Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity.
    T Dennis, A Fournier, S St Pierre and R Quirion
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 718-725;
  • You have access
    Activity of selective dopamine DA1 and DA2 agonists and antagonists on experimental gastric lesions and gastric acid secretion.
    G B Glavin
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 726-730;
  • You have access
    Kinin antagonist does not protect against the hypotensive response to endotoxin, anaphylaxis or acute pancreatitis.
    T Berg, E Schlichting, H Ishida and O A Carretero
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 731-734;
  • You have access
    Food deprivation and acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and haloperidol.
    J De Vry, I Donselaar and J M Van Ree
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 735-740;
  • You have access
    Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious rats.
    E J van Hoogdalem, C D Heijligers-Feijen, R A Mathôt, A T Wackwitz, J B van Bree, J C Verhoef, A G de Boer and D D Breimer
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 741-744;
  • You have access
    Effect of various chemical modifiers on H+ coupled transport of cephradine via dipeptide carriers in rabbit intestinal brush-border membranes: role of histidine residues.
    M Kato, H Maegawa, T Okano, K Inui and R Hori
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 745-749;
  • You have access
    Renal handling of salicyluric acid in the isolated perfused rat kidney: evidence for accumulation in tubular cells.
    P G Cox, W M Moons, F G Russel and C A van Ginneken
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 750-755;
  • You have access
    Time- and voltage-dependent block of the delayed K+ current by quinidine in rabbit sinoatrial and atrioventricular nodes.
    T Furukawa, Y Tsujimura, K Kitamura, H Tanaka and Y Habuchi
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 756-763;
  • You have access
    Divergent pharmacological effects of three calmodulin antagonists, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), chlorpromazine and calmidazolium, on isometric tension development and myosin light chain phosphorylation in intact bovine tracheal smooth muscle.
    M Asano
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 764-773;
  • You have access
    Rioprostil heals pre-existing aspirin-induced gastric lesions in dogs during daily aspirin administration without altering the anti-inflammatory or analgesic efficacy of aspirin.
    L B Katz and D A Shriver
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 774-781;
  • You have access
    Critical period of phenytoin teratogenic action in the sea urchin, Arbacia punctulata embryo.
    S Estus and J L Blumer
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 782-789;
  • You have access
    Identification and induction of cytochromes P450, P450IIE1 and P450IA1 in rabbit bone marrow.
    G G Schnier, C L Laethem and D R Koop
    Journal of Pharmacology and Experimental Therapeutics November 1989, 251 (2) 790-796;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 251, Issue 2
1 Nov 1989
  • Table of Contents
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics